At MapmyGenome, we believe that the secret to a long, healthy life is written in your DNA. Since 2013, we have pioneered the shift from "sick-care" to "preventive healthcare" in India. By combining world-class genomic sequencing with actionable health insights, we empower At MapmyGenome, we believe that the secret to a long, healthy life is written in your DNA. Since 2013, we have pioneered the shift from "sick-care" to "preventive healthcare" in India. By individuals, healthcare providers, and clinical organizations to move beyond guesswork and embrace precision medicine.

Our Vision: To touch 100 million lives by making genomics an integral part of healthcare, empowering every individual to make informed decisions about their wellness and lifestyle.

MapmyGenome was founded on a singular, urgent premise: Healthcare should be proactive, not reactive. Closing the Global Data Gap When we launched in 2013, we identified a critical flaw in global precision medicine: under-representation. While genomic research was accelerating, data specific to the Indian population—comprising one-sixth of the world’s people—was virtually non-existent. We didn't just want to provide tests; we wanted to build the genomic foundation for an entire subcontinent. From India we are now expanding to the rest of the world starting with Canada.

From "Sick-Care" to "Self-Care"

Our mission was to move the epicenter of healthcare from the hospital bed to the individual's home. We pioneered  Genomepatri™—a genomic roadmap that translates complex DNA sequencing into a culturally resonant "blueprint for life."

Our Core Objectives:

• Preventive Precision: Identifying genetic predispositions to chronic diseases before symptoms emerge.
• Democratizing DNA: Making high-fidelity genomic insights accessible, affordable, and actionable for 1.4 billion people.
• Empowering Longevity: Using the Epigenome and Microbiome as dynamic tools to manage biological aging in real-time.
  

Led by pioneers in molecular biology and data science, our team includes dozens of PhDs and Genetic Counselors who have interpreted over 100,000  genomes."

We are a multidisciplinary team of geneticists, bioinformaticians, data scientists, and healthcare counselors committed to bringing "Genomics for All" by merging cutting-edge technology with empathetic human guidance. Our global footprint includes MapmyGenome India, an NABL-certified and CAP-accredited genomics laboratory, and our Canada-based company, Microbiome Insights, which is a CAP-accredited leader in microbiome research and genomics services. We are more than just a testing facility; we are a dedicated group of innovators providing actionable health data through world-class laboratory standards.

Our Core Strengths:

• Global Accreditations: Both our Indian and Canadian operations maintain CAP accreditation, ensuring the highest international standards of quality.
• Microbiome Specialization: Our Canadian entity, Microbiome Insights, leads the way in advanced microbiome research and specialized genomics services.
• Comprehensive Genomics: We offer a full spectrum of genetic testing and bioinformatics through our NABL-certified facilities in India.

Innovation-Driven: Bridging the gap between complex biological data and personalized healthcare for a global audience.

Our Integrated Ecosystem: The Full Spectrum of Life

We provide a "Multi-Omics" platform that bridges the gap between your ancestral past and your healthy future. By integrating Preventive Genomics, Epigenetics, and Pharmacogenomics, we offer the world's most comprehensive roadmap for longevity.

1. Longevity & The Epigenome

We focus on Healthspan—extending the years you spend in peak health. While your DNA is fixed, your Epigenome is dynamic. We track biological aging and gene expression, allowing you to monitor how lifestyle changes actively "turn on" or "off" health-related genes.

2. MedicaMap: Precision Pharmacogenomics

Genetic variation determines how you metabolize medication. Our MedicaMap platform analyzes your unique response to over 100+ FDA-approved drugs.

• The Benefit: Eliminating the "trial-and-error" approach to medicine.
• The Impact: Reducing Adverse Drug Reactions (ADRs) and optimizing treatments for cardiology, oncology, and psychiatry.

3. Heritage: Ancestry & Population Genetics

Our Genomepatri Heritage analysis dives into your roots, mapping your ancestral origins and ethnic composition. For the Indian subcontinent—a region with immense genetic diversity—we provide localized insights that global competitors often overlook, connecting you to your biological history.

4. Microbiome & Metagenomic Excellence

Through our dual-accredited operations—NABL-certified labs in India and our CAP-accredited Canadian leader, Microbiome Insights—we offer:

• Gut Health: Deep-dive metagenomic sequencing of the microbiome.
• Clinical Genomics: Precision support for rare diseases and advanced diagnostics.
• Global Research: Partnering with institutions to provide high-fidelity genomic data for the next generation of biotech.